Luciana Basili Dias Candidíase vulvovaginal em pacientes gestantes

Referências Bibliográficas 97
Richter SS, Galask RP, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA. Antifungal
susceptibilities of Candida Species Causing Vulvovaginitis and Epidemiology of Recurrent
Cases. J Clin Microbiol. 2005; 43: 2155-62.
Rippon JW. Candidiasis. In: Medical Mycology. The pathogenic fungi and the pathogenic
actinomycetes. 3ª ed. Philadelphia: W. B. Saunders Company; 1988. p.536-81.
Rippon JW. Candidiasis and the pathogenic yeast. In: Medical Mycology. The pathogenic fungi
and pathogenic actinomycetes. 3ª ed. Philadelphia: W. B. Saunders Company; 1988a. p. 532-81.
Rodriguez-Tudella JL, Rodero L, Cuenca-Estrella M, Cordoba S. Curso Ibero-Americano
“Antifúngicos: Abordagem terapêutica e laboratorial”. 4ª ed. São Paulo; 2003. p. 218.
Rose AH, Harrison JS. The Yeasts. London: Academic Press; 1989. p.261-87.
Saag MS, Dismukes WE. Azoles antifungal agents: emphasis on new triazoles. Antimicrob.
Agents Chemother. 1988; 32: 1-8.
Sanchez ML, Jones RN. E-test, an antimicrobial susceptibility testing method with broad clinical
and epidemiology application. Antimicrob. News. 1992; 8: 1-7.
Sanglard D, Ischer F, Monod M, Biller J. Cloning of Candida albicans genes conferring
resistance to azole antifungal agents: characterization of CRD2, a new multidrug ABC
transporter gene. Microbiology. 1997; 143: 405-16.
Segal E, Baum GL. Pathogenic yeasts and Yeast infections. Florida: CRC Press; 1994. p. 227.
Sheehan DJ, Hitchoock CA, Sibley CM. Current and emerging azole antifungal agents. Clin.
Microbiol. Rev. 1999; 12: 40-79.
Shimokawa O, Nakayama H. Increased sensitivity of Candida albicans cells accumulating 14 α-
methylated sterols to active oxygen: possible relevance to “in vivo” efficacies of azoles antfungal
agents. Antimicrob. Agents Chemother. 1992; 36:1626-9.